期刊
CHEMICAL SCIENCE
卷 9, 期 36, 页码 7261-7270出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/c8sc00900g
关键词
-
资金
- Wellcome Trust [098493/Z/12/Z]
- Foundation Alfonso Martin Escudero (FAME, Spain)
- EPSRC [EP/L016559/1]
- MRC Centre for Doctoral Training in Optical Medical Imaging OPTIMA [EP/L016559/1]
- Scottish Funding Council [H14052]
- FP7 Marie Curie Integration Grant [333847]
- Biotechnology and Biological Sciences Research Council [BB/M025160/1]
- Royal Society [RG160289]
- ERC Consolidator Grant [771443]
- MSCA Individual Fellowship [704912]
- Wellcome Trust [098493/Z/12/Z] Funding Source: Wellcome Trust
- BBSRC [BB/M025160/1] Funding Source: UKRI
- EPSRC [EP/M507258/1] Funding Source: UKRI
- MRC [G0901697] Funding Source: UKRI
Herein tricarbocyanine N-triazoles are first described as a rationally-designed near-infrared (NIR) structure overcoming the brightness and photostability limitations of tricarbocyanines for long-term in vivo imaging. The straightforward synthetic approach and the wide availability of alkynes makes this strategy a versatile methodology for the preparation of highly stable N-substituted tricarbocyanines. Furthermore, we validated CIR38M as a non-transferable marker to monitor the fate of therapeutic T cells non-invasively in vivo, showing enhanced performance over conventional NIR fluorophores (i.e.DiR, IR800CW and indocyanine green) as well as compatibility with human cells for translational studies. CIR38M is able to track over time smaller numbers of T cells than current NIR agents, and to visualise antigen-driven accumulation of immune cells at specific sites in vivo. This chemical technology will improve longitudinal imaging studies to assess the efficacy of cell-based immunotherapies in preclinical models and in human samples.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据